🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A Multi-Center, Open-Label, Phase 2 Clinical Trial to Evaluate the Safety, ...
Status
Completed
Location
TCR Medical Corporation
Start Date
2021-05-07
Trial ID
NCT04908514
Treatments Being Tested
A Clinical Trial Investigating the Safety and Efficacy of ADX-629 in Subjec...
Status
Withdrawn
Location
Amicis Research Center - Northridge
Start Date
2023-01
Trial ID
NCT05599815
Treatments Being Tested
A Phase 2 Clinical Trial Investigating the Safety and Efficacy of ADX-629 i...
Status
Completed
Location
Synergry Healthcare
Start Date
2024-11-04
Trial ID
NCT06685692
A Phase 2, multicenter, adaptive 2-part clinical trial designed to evaluate...
Status
Completed
Location
Bexley Dermatology Research
Start Date
2023-02-15
Trial ID
NCT05717920
Treatments Being Tested
A Double Masked, Placebo Controlled, Single Center, Randomized Clinical Tri...
Status
Completed
Location
Cliantha Research
Start Date
2021-01-09
Trial ID
NCT04728711
This research study will determine whether orally administered ADX-629 is s...
Status
Completed
Location
University of Nebraska Medical Center
Start Date
2023-01-02
Trial ID
NCT05443685
Treatments Being Tested
A Randomized, Double-Blind, Placebo-Controlled, Clinical Trial to Evaluate ...
Status
Completed
Location
Medical Research Center of Miami II, Inc.
Start Date
2021-03-31
Trial ID
NCT04847544
A Double-Blind Trial to Assess the Interaction Between ADX-629 and Ethanol ...
Status
Completed
Location
Medpace Clinical Pharmacology
Start Date
2021-11-15
Trial ID
NCT05487404
A Randomized, Double-Blind, Placebo-Controlled, Two-Period Crossover, Phase...
Status
Completed
Location
Allergy Associates Medical Group, Inc.
Start Date
2022-04-07
Trial ID
NCT05392192